Francesco Giuseppe De Rosa Selected Research

Cross Infection (Nosocomial Infection)

2/2024	Epidemiology and Risk Factors for Nosocomial Infections in Left Ventricular Assist Device Recipients.
4/2023	Nosocomial Infections in Adult Patients Supported by Extracorporeal Membrane Oxygenation in a Cardiac Intensive Care Unit.
7/2011	Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Giuseppe De Rosa Research Topics

Disease

50	Infections 03/2024 - 01/2008
32	Sepsis (Septicemia) 04/2024 - 03/2011
23	COVID-19 11/2023 - 01/2020
19	Pneumonia (Pneumonitis) 04/2024 - 10/2013
14	Septic Shock (Toxic Shock Syndrome) 04/2024 - 07/2015
13	Endocarditis 01/2024 - 12/2002
12	Critical Illness (Critically Ill) 12/2022 - 03/2011
9	Candidemia 07/2023 - 03/2011
7	Communicable Diseases (Infectious Diseases) 01/2023 - 12/2013
6	Healthcare-Associated Pneumonia 04/2024 - 01/2019
6	Neoplasms (Cancer) 01/2024 - 06/2014
6	Bacterial Infections (Bacterial Infection) 01/2023 - 12/2013
5	Bacteremia 01/2024 - 01/2019
5	Fever (Fevers) 12/2023 - 01/2017
5	Neutropenia 03/2023 - 06/2014
4	Acute Kidney Injury (Acute Renal Failure) 11/2023 - 09/2021
4	Invasive Fungal Infections 01/2021 - 12/2007
3	Cross Infection (Nosocomial Infection) 02/2024 - 07/2011
3	Febrile Neutropenia 01/2024 - 01/2017
3	Invasive Candidiasis 07/2023 - 12/2016
3	Candidiasis (Moniliasis) 07/2023 - 12/2013
3	Disease Progression 01/2023 - 01/2021
3	Burns 09/2021 - 01/2017
3	Mycoses (Diseases, Fungus) 01/2021 - 06/2015
2	Coinfection 01/2024 - 07/2023
2	Non-Muscle Invasive Bladder Neoplasms 03/2023 - 12/2017
2	Hypertension (High Blood Pressure) 02/2023 - 11/2022
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 12/2013
2	Echinococcosis (Hydatid Cysts) 01/2023 - 06/2017
2	Respiratory Insufficiency (Respiratory Failure) 11/2022 - 08/2021
2	Superinfection 09/2022 - 08/2021
2	Urinary Tract Infections (Urinary Tract Infection) 04/2022 - 01/2019
2	Intraabdominal Infections 04/2022 - 12/2013
2	Central Nervous System Infections (Central Nervous System Infection) 04/2022 - 01/2016
2	Anastomotic Leak 10/2021 - 12/2013
2	Surgical Wound Infection 10/2021 - 03/2021
2	HIV Infections (HIV Infection) 05/2021 - 01/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2021 - 01/2018
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021 - 01/2014
2	Inflammation (Inflammations) 01/2021 - 01/2020
2	Respiratory Tract Infections (Respiratory Tract Infection) 07/2020 - 01/2020
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 07/2015

Drug/Important Bio-Agent (IBA)

22	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 03/2008
15	Carbapenems (Carbapenem Antibiotics)IBA 10/2023 - 07/2005
10	carbapenemaseIBA 04/2023 - 06/2015
7	Colistin (Coly-Mycin)FDA Link 01/2021 - 07/2015
6	ceftazidime drug combination avibactamIBA 11/2023 - 01/2019
5	AzolesIBA 07/2023 - 12/2013
4	ceftobiproleIBA 04/2024 - 01/2019
4	dalbavancinIBA 01/2024 - 01/2021
4	CefiderocolIBA 01/2024 - 09/2022
4	Oxygen (Dioxygen)IBA 11/2023 - 01/2021
4	SteroidsIBA 07/2023 - 12/2007
4	Biomarkers (Surrogate Marker)IBA 05/2023 - 12/2016
4	FluoroquinolonesIBA 03/2023 - 06/2014
4	Daptomycin FDA Link 01/2022 - 02/2015
4	AminoglycosidesIBA 10/2021 - 01/2019
3	Cephalosporins (Cephalosporin Antibiotics)IBA 04/2024 - 07/2020
3	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 12/2023 - 03/2008
3	Vancomycin FDA LinkGeneric 06/2023 - 01/2008
3	beta-Lactamases (beta-Lactamase)IBA 03/2023 - 10/2021
3	Monoclonal AntibodiesIBA 01/2023 - 12/2021
3	Levofloxacin (Levaquin)FDA Link 01/2023 - 12/2013
3	beta-LactamsIBA 01/2022 - 10/2021
3	Antiviral Agents (Antivirals)IBA 12/2021 - 01/2021
3	Gentamicins (Gentamicin)FDA LinkGeneric 10/2021 - 04/2017
2	Immunoglobulin E (IgE)IBA 01/2024 - 07/2019
2	VaccinesIBA 11/2023 - 01/2023
2	LactamsIBA 10/2023 - 02/2021
2	CytokinesIBA 05/2023 - 01/2021
2	Tigecycline (Tygacil)FDA Link 04/2023 - 04/2017
2	Meropenem (Merrem)FDA LinkGeneric 03/2023 - 01/2020
2	C-Reactive ProteinIBA 01/2023 - 05/2021
2	Immunomodulating AgentsIBA 11/2022 - 01/2021
2	meropenem and vaborbactamIBA 10/2022 - 03/2022
2	LipoglycopeptidesIBA 09/2022 - 09/2021
2	Methicillin (Metin)FDA Link 06/2022 - 01/2008
2	remdesivirIBA 12/2021 - 01/2021
2	Intravenous Immunoglobulins (IVIG)FDA Link 08/2021 - 07/2019
2	GlycopeptidesIBA 02/2021 - 01/2008
2	Oxazolidinones (2 Oxazolidone)IBA 02/2021 - 10/2013
2	Caspofungin (Cancidas)FDA Link 01/2021 - 04/2013

Therapy/Procedure

58	Therapeutics 04/2024 - 01/2003
7	Artificial Respiration (Mechanical Ventilation) 11/2023 - 01/2019
6	Length of Stay 11/2023 - 12/2002
5	Liver Transplantation 04/2023 - 06/2017
4	Drug Therapy (Chemotherapy) 03/2024 - 01/2019
4	Hematopoietic Stem Cell Transplantation 01/2024 - 01/2020
4	Critical Care (Surgical Intensive Care) 04/2022 - 12/2013
3	Central Venous Catheters 01/2024 - 06/2014
3	Catheters 12/2023 - 02/2021
3	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2023 - 12/2022
3	Noninvasive Ventilation 11/2023 - 12/2021
3	Duration of Therapy 07/2023 - 06/2016
3	Extracorporeal Membrane Oxygenation 04/2023 - 01/2014
3	Off-Label Use 04/2023 - 09/2021
3	Parenteral Nutrition 09/2022 - 11/2019
2	Antibiotic Prophylaxis 10/2021 - 12/2013
2	Immunotherapy 08/2021 - 12/2017
2	Cardiopulmonary Bypass (Heart-Lung Bypass) 08/2020 - 03/2011